Cancer tumour on ovarian wall
Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- Nucala (mepolizumab) is the first treatment to show a significant reduction in flares for patients with Hypereosinophilic Syndrome (HES)
- EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV
- GSK delivers sales of £9.4 billion +16% AER, +11% CER (Pro-forma +6% CER*)
Tweets from GSK
-
GSK @GSK
We’re combining our vaccine expertise with Viome’s proprietary microbiome analysis and artificial intelligence platforms. This is a promising step forward in developing broader, vaccine-based therapies to help prevent and treat chronic diseases. Find out more:
about 13 hours ago -
GSK @GSK
20 November is 🌏 World COPD Day. Sara Latham, from@COPDFoundationn explains why talking openly with healthcare professionals can help patients better manage their condition.a
about 13 hours ago -
GSK @GSK
We’re proud to be inspiring the next generation of scientists 👩🔬👨🔬 in the possibilities of medicine, as principal sponsor of ‘Medicine: The Wellcome Galleries’ at @sciencemuseumseum
about 19 hours ago
